Laboratory diagnosis of neurocysticercosis (taenia solium)

the Cysticercosis Working Group in Peru

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

43 Citas (Scopus)


Neurocysticercosis accounts for approximately 30% of all epilepsy cases in most developing countries. The immunodiagnosis of cysticercosis is complex and strongly influenced by the course of infection, the disease burden, the cyst location, and the immune response of the host. The main approach to immunodiagnosis should thus be to evaluate whether the serological results are consistent with the diagnosis suggested by imaging. Antibody detection is performed using lentil lectin-purified parasite antigens in an enzyme-linked immunoelectrotransfer blot format, while antigen detection uses a monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA). Promising new assay configurations have been developed for the detection of both antibody and antigen, including assays based on synthetic or recombinant antigens that may reduce costs and improve assay reproducibility and multiplex bead-based assays that may provide simultaneous quantitative results for several target antigens or antibodies.

Idioma originalInglés
Número de artículoe00424
PublicaciónJournal of Clinical Microbiology
EstadoPublicada - set. 2018

Nota bibliográfica

Publisher Copyright:
© 2018 American Society for Microbiology. All Rights Reserved.


Profundice en los temas de investigación de 'Laboratory diagnosis of neurocysticercosis (taenia solium)'. En conjunto forman una huella única.

Citar esto